Expired semaglutide can complicate health management by failing to deliver expected results, leading to weight loss plateaus or poor glycemic control, which can have serious health implications
Transitioning to a medication like Wegovy, suitable for its approved use, can also streamline insurance coverage as insurers are more likely to fund drugs prescribed for their designated purpose
The trial included over 3,400 people with a BMI of 30 or above (or 27+ with at least one weight-related health condition) and without type 2 diabetes
If you have questions about pricing or need assistance, please contact our office for personalized support
WHO and EMA Warnings About Semaglutide and NAION In June 2025, the World Health Organization alerted healthcare professionals and regulatory authorities to the risk of non-arteritic anterior ischemic optic neuropathy (NAION) associated with semaglutide medications, including Ozempic, Rybelsus, and Wegovy